Post job

Explore jobs

Find specific jobs

Explore careers

Explore professions

Best companies

Explore companies

Working at Brainstorm Cell Therapeutics

Zippia score 4.0

Overview

Revenue

Reviews

CEO & Executives

Brainstorm Cell Therapeutics overview

Industry
Biotechnology
Revenue
$82K
Headquarters
Employees
40
Founded in
Website
Organization type
Public
Social media
BrainStorm Cell Therapeutics is a biotechnology company developing innovative, autologous stem cell therapies for highly debilitating neurodegenerative diseases such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Multiple Sclerosis (MS) and Parkinson's Disease (PD). NurOwn™, our proprietary, first-of-its-kind technology for the propagation and differentiation of autologous Mesenchymal Stem Cells (MSCs) into NeuroTrophic Factor (NTF)-secreting cells and their transplantation at or near the site of damage, offers the hope of conquering neurodegenerative diseases. We are currently conducting a Phase IIa ALS clinical trial with NurOwn at the Hadassah University Medical Center in Jerusalem. In this safety and preliminary efficacy trial, 12 patients will receive combined intramuscular and intrathecal administration of neuron cells in three cohorts with increasing doses. The study participants will be followed for three to six months after transplantation. The company also plans to begin a Phase II clinical trial in the USA in 2013, pending FDA approval. On February 2011, NurOwn was granted Orphan Drug designation by the FDA. Over 20 publications in leading scientific journals demonstrating neuron mechanism of action, pharmacology and in vivo efficacy have been published by the scientific team.
Brainstorm Cell Therapeutics is a small health care company based in New York, NY with only 40 employees and an annual revenue of $82,000.

Brainstorm Cell Therapeutics's mission statement

Committed to developing the innovative scientific achievements of our academic collaborators from the lab to the clinic.

In demand companies are hiring! Let Zippia apply for you!

Floating question marks illustration
-

Brainstorm Cell Therapeutics employee reviews

Be the first to review!

Do you work at Brainstorm Cell Therapeutics?

Help job seekers learn about working at Brainstorm Cell Therapeutics

On this page

Be the first to review Brainstorm Cell Therapeutics

Anonymously rate your employee experience

Your opinion can help other job seekers

Do you like working at Brainstorm Cell Therapeutics?

The team at Brainstorm Cell Therapeutics

  • The founders of Brainstorm Cell Therapeutics is Daniel Offen.
  • The key people at Brainstorm Cell Therapeutics are Chaim Lebovits and Daniel Offen.
Key people
Chaim Lebovits
Daniel Offen

Rate Brainstorm Cell Therapeutics' promotion and raise policies.

Zippia waving zebra

Do you work at Brainstorm Cell Therapeutics?

Were you satisfied with Brainstorm Cell Therapeutics' salary and benefits?

Brainstorm Cell Therapeutics financial performance

8.7
Performance score

Brainstorm Cell Therapeutics annual revenue

$85,000
$68,000
$51,000
$34,000
$17,000
$0
2021

Are you an executive, HR leader, or brand manager at Brainstorm Cell Therapeutics?

Claiming and updating your company profile on Zippia is free and easy.

Brainstorm Cell Therapeutics FAQs

Have more questions? See all answers to common company questions.

Search for jobs

Most in demand jobs

Related companies

Related company jobs

Related company salaries

    Updated March 14, 2024

    Zippia gives an in-depth look into the details of Brainstorm Cell Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Brainstorm Cell Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at Brainstorm Cell Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Brainstorm Cell Therapeutics. The data presented on this page does not represent the view of Brainstorm Cell Therapeutics and its employees or that of Zippia.

    Brainstorm Cell Therapeutics may also be known as or be related to BRAINSTORM CELL THERAPEUTICS INC., Brainstorm Cell Therapeutics, Brainstorm Cell Therapeutics Inc, Brainstorm Cell Therapeutics Ltd, Brainstorm Cell Therapeutics Ltd. and Brainstorm Cell Therapeutics, Inc.